IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 3 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $119,833 | -59.9% | 26,337 | -37.9% | 0.01% | -54.5% |
Q2 2023 | $298,707 | +343.3% | 42,430 | +284.8% | 0.01% | +266.7% |
Q1 2023 | $67,375 | -90.2% | 11,027 | -89.7% | 0.00% | -91.7% |
Q4 2022 | $684,235 | -42.3% | 107,079 | -13.4% | 0.04% | -21.7% |
Q3 2022 | $1,185,000 | – | 123,644 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |